These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 4677646)

  • 1. [ABO hemolytic disease of the newborn. Treatment by exsanguination transfusion].
    Lange MM
    Pathologica; 1972; 64(935):315-24. PubMed ID: 4677646
    [No Abstract]   [Full Text] [Related]  

  • 2. [The exchange transfusion in hemolytic disease of the newborn due to ABO-incompatibility].
    Olearczyk J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(3):364-5. PubMed ID: 4193015
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of AB substance for the exsanguination transfusion in ABO system incompatibility].
    Ruttkay F; Fabian P; Calkovská Z
    Cesk Pediatr; 1972 Nov; 27(11):554-5. PubMed ID: 4673826
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood group and sex of infants treated with exchange transfusion for hemolytic ABO disease].
    Hodr R; Vondrácek J; Skutilová J
    Cesk Pediatr; 1988 Apr; 43(4):245-7. PubMed ID: 3396111
    [No Abstract]   [Full Text] [Related]  

  • 5. [A few remarks of the immunohematologist in connection with administration of exchange transfusions in the newborn with hemolytic disease (with respect to the transfusion material)].
    Kulich V; Sauer J
    Cesk Gynekol; 1969 Oct; 34(8):488-90. PubMed ID: 5354332
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemolytic disease of newborn].
    Speilmann W
    Dtsch Med Wochenschr; 1975 Sep; 100(38):1918. PubMed ID: 1192959
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemolytic disease of the newborn from the viewpoint of the pediatrician].
    Janovský M; Polácek K
    Cesk Gynekol; 1969 Oct; 34(8):485-8. PubMed ID: 4982153
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of washed group O erythrocytes suspended in 5% albumin administered in ABO group-related hemolytic disease of the newborn].
    Pedich M; Reperowicz-Iszczuk J; Maślińska T
    Pediatr Pol; 1975 Aug; 50(8):1023-7. PubMed ID: 1172227
    [No Abstract]   [Full Text] [Related]  

  • 9. [Incidence of neonates treated with exchange transfusion for hemolytic disease due to ABO system incompatibility during the past 16 years].
    Hodr R; Zoban P; Hromádková L; Kepertová M; Skutilová J
    Cesk Pediatr; 1987 Aug; 42(8):464-6. PubMed ID: 3664755
    [No Abstract]   [Full Text] [Related]  

  • 10. Complement in ABO--hemolytic disease of the newborn.
    Wang MY; Desforges JF
    Pediatrics; 1971 Oct; 48(4):650-3. PubMed ID: 5165506
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemolytic disease of the newborn].
    Nakayama K; Fujisawa S
    Rinsho Byori; 1967; ():Suppl 14:61-70. PubMed ID: 4969613
    [No Abstract]   [Full Text] [Related]  

  • 12. [Production of KU-ABO preparations in hospitals for the treatment of hemolytic disease of the newborn].
    Cwik J; Dimmich H; Przudzik J
    Pediatr Pol; 1985 Sep; 60(9):658-61. PubMed ID: 3831899
    [No Abstract]   [Full Text] [Related]  

  • 13. [ABO hemolytic disease of the newborn. Criteria for prognostic and therapeutic evaluation (except exsanguination transfusion)].
    Salvioli GP
    Pathologica; 1972; 64(935):309-14. PubMed ID: 4671451
    [No Abstract]   [Full Text] [Related]  

  • 14. [Erythropoietic activity in newborn infants with maternal-fetal incompatibility in the ABO system treated with exchange transfusion. Use of the Ashby method in 14 cases].
    Stegagno G; Mencarini L; Orvieto G
    Minerva Pediatr; 1968 Oct; 20(41):2131-42. PubMed ID: 5754726
    [No Abstract]   [Full Text] [Related]  

  • 15. [Isoagglutinins of the ABO system in universal blood preparations (KU-ABO) used for exchange transfusions in hemolytic disease of the newborn].
    Cwik J
    Pediatr Pol; 1985 Sep; 60(9):652-7. PubMed ID: 3831898
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of the direct antiglobulin test in capillary tubes in the diagnosis of ABO hemolytic disease of the newborn. Critical review after 7 years experience].
    Andreoni MG; Moroni GA; Cossu MM; Agosti S
    Ann Ostet Ginecol Med Perinat; 1979; 100(5):333-40. PubMed ID: 263617
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-statistical considerations on newborn infants treated with exchange transfusions for hemolytic disease caused by Rh isoimmunization or ABO incompatibility and for hyperbilirubinemia of non-immunological causes in full-term newborn infant. (Examination of 462 cases)].
    Di Piero G; Mencarini L; Ottaviano S; Lapi AS
    Riv Clin Pediatr; 1967; 80(4):89-112. PubMed ID: 4974851
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of the blood serum examination for the presence of anti-ABO system antibodies in mothers of newborn infants with fetal erythroblastosis requiring exchange transfusion].
    Cwik J
    Pediatr Pol; 1988 Sep; 63(9):563-8. PubMed ID: 3253666
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemolytic disease of newborn caused by anti-c antibody].
    Tóth A; Vágvölgyi E; Trézli I
    Orv Hetil; 1982 Aug; 123(32):1983-4. PubMed ID: 6815609
    [No Abstract]   [Full Text] [Related]  

  • 20. Recurrence rate of ABO hemolytic disease of the newborn.
    Katz MA; Kanto WP; Korotkin JH
    Obstet Gynecol; 1982 May; 59(5):611-4. PubMed ID: 7070734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.